<DOC>
	<DOC>NCT00847288</DOC>
	<brief_summary>Medtronic, Inc. is sponsoring the OptiVol® Care Pathway Study, a prospective, randomized, multi-center, post-market clinical trial in the United States. The purpose of this clinical trial is to compare monthly versus quarterly review of Cardiac Compass® Trends with OptiVol for initiation of clinical action. It is hypothesized that monthly review of Cardiac Compass Trends with OptiVol will shorten time to clinical action as compared to quarterly review.</brief_summary>
	<brief_title>OptiVol® Care Pathway</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Subject (or subject's legally authorized representative) is willing and able to sign and date written consent form and Authorization for Access to and Use of Health Information Subject is at least 18 years of age Subject is willing and able to comply with Clinical Investigation Plan Subject is willing and able to transmit data using Medtronic CareLink® Network Subject has market released right atrial (RA) (if applicable), right ventricular (RV), and left ventricular (LV) (if applicable) leads and one of the following generators implanted: Concerto® CRTD Model C154DWK, Virtuoso® DR ICD Model D154AWG, Virtuoso® VR ICD Model D154VWC, Consulta™ CRTD Model D224TRK, Secura™ DR ICD Model D224DRG, Secura™ VR ICD Model D224VRC, or any future market released Medtronic generator with wireless telemetry, Cardiac Compass with OptiVol Fluid Status Monitoring, and that is supported by the Medtronic CareLink Network Subject is enrolled in a concurrent study with the exception of a study approved by the Medtronic Clinical Trial Leader prior to enrollment Subject has life expectancy of less than 1 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Implantable Cardioverter Defibrillator (ICD)</keyword>
	<keyword>Cardiac Resynchronization Therapy with Defibrillator (CRT D)</keyword>
	<keyword>OptiVol®</keyword>
</DOC>